Adlai Nortye Group Ltd. (ANL)Healthcare | Biotechnology | North Brunswick, United States | NasdaqGM
13.82 USD
-0.50
(-3.492%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 13.82 |
Hot Take ↕ | Aug. 22, 2026, 4:56 a.m. EDT
The immediate outlook is neutral-to-slightly-bearish despite a recent price bounce, as the underlying business fundamentals remain severely impaired. While the stock has rallied roughly 65% in the last week and sits above its 50-day moving average, suggesting some short-term momentum, the company is burning significant cash with negative operating cash flow of -$33.7 million and negative free cash flow. The balance sheet is fragile, showing negative book value and a debt-to-equity ratio that implies equity erosion. Furthermore, the price action reveals a brutal multi-year reality: the stock has lost nearly half its value (-45.6%) over the last year, indicating that the market has already priced in a severe deterioration in business quality. With no dividend history and a forward P/E that is negative due to losses, there is no safety margin for a long-term holder. The recent price surge appears to be driven by financing news and speculative sentiment rather than a turnaround in core operations, leaving the investment case fundamentally hollow. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.103017 |
| AutoTheta | 0.103406 |
| MSTL | 0.105866 |
| AutoARIMA | 0.118752 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 0.64 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.286 |
| Excess Kurtosis | -1.07 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 12.429 |
| Revenue per Share | 0.453 |
| Market Cap | 889,979,456 |
| Forward P/E | -47.11 |
| Beta | 1.12 |
| Profit Margins | -124.77% |
| Previous Name | Adlai Nortye Ltd. |
| Website | https://www.adlainortye.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 7.044944 |
| Address1 | New Jersey Biotechnology Dev Ctr |
| Address2 | 2nd floor 685 US Hwy 1 |
| All Time High | 19.3 |
| All Time Low | 0.879 |
| Ask | 16.89 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 145,920 |
| Average Daily Volume3 Month | 180,200 |
| Average Volume | 180,200 |
| Average Volume10Days | 145,920 |
| Beta | 1.119 |
| Bid | 9.29 |
| Bid Size | 2 |
| Book Value | 3.336 |
| City | North Brunswick |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 13.82 |
| Current Ratio | 9.55 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 14.45 |
| Day Low | 13.53 |
| Debt To Equity | 12.429 |
| Display Name | Adlai Nortye |
| Earnings Timestamp End | 1,755,864,000 |
| Earnings Timestamp Start | 1,754,650,740 |
| Ebitda | -21,650,500 |
| Ebitda Margins | -1.19908 |
| Enterprise To Ebitda | -33.074 |
| Enterprise To Revenue | 39.658 |
| Enterprise Value | 716,062,464 |
| Eps Current Year | -0.17167 |
| Eps Forward | -0.29333 |
| Eps Trailing Twelve Months | -0.66 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 12.0984 |
| Fifty Day Average Change | 1.7215996 |
| Fifty Day Average Change Percent | 0.14229977 |
| Fifty Two Week Change Percent | 704.4944 |
| Fifty Two Week High | 17.25 |
| Fifty Two Week High Change | -3.4300003 |
| Fifty Two Week High Change Percent | -0.1988406 |
| Fifty Two Week Low | 0.879 |
| Fifty Two Week Low Change | 12.941 |
| Fifty Two Week Low Change Percent | 14.722412 |
| Fifty Two Week Range | 0.879 - 17.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,695,994,200,000 |
| Float Shares | 44,781,037 |
| Forward Eps | -0.29333 |
| Forward P E | -47.11417 |
| Free Cashflow | -11,449,125 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 109 |
| Fullday Change | -0.5 |
| Fullday Change Percent | -3.49162 |
| Fullday Price | 13.82 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 18,056,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0057200002 |
| Held Percent Institutions | 0.45194998 |
| Implied Shares Outstanding | 64,397,938 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,023-09-29 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies. Its RAS-targeting programs include AN9025, an oral pan-RAS(ON) inhibitor for RAS-driven cancers, and AN4035, a CEACAM5-targeting antibody-drug conjugate that delivers a pan-RAS(ON) inhibitor to tumors. Its immunotherapy programs include AN8025, a tri-functional fusion protein (aPD-L1 x CD86 variant x LAG3 variant) that modulates T-cells and antigen-presenting cells; AN0025, a small molecule EP4 antagonist; and AN4005, an oral small-molecule PD-L1 inhibitor. The company supports its pipeline through an immuno-oncology research and development platform with operations in the United States and China. Adlai Nortye Group Ltd. was formerly known as Adlai Nortye Ltd. and changed its name to Adlai Nortye Group Ltd. in July, 2026. Adlai Nortye Group Ltd. was founded in 2004 and is based in North Brunswick, New Jersey. |
| Long Name | Adlai Nortye Group Ltd. |
| Market | us_market |
| Market Cap | 889,979,456 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1830112145 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -22,529,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 917,026,631 |
| Number Of Analyst Opinions | 5 |
| Open | 14.41 |
| Operating Cashflow | -33,685,000 |
| Operating Margins | -0.44187 |
| Payout Ratio | 0.0 |
| Phone | 848 230 7430 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 13.82 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Adlai Nortye Ltd. |
| Previous Close | 14.32 |
| Price Eps Current Year | -80.50329 |
| Price Hint | 2 |
| Price To Book | 4.142686 |
| Price To Sales Trailing12 Months | 49.289955 |
| Profit Margins | -1.24773 |
| Quick Ratio | 9.241 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.5 |
| Regular Market Change Percent | -3.49162 |
| Regular Market Day High | 14.45 |
| Regular Market Day Low | 13.53 |
| Regular Market Day Range | 13.53 - 14.45 |
| Regular Market Open | 14.41 |
| Regular Market Previous Close | 14.32 |
| Regular Market Price | 13.82 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 165,027 |
| Return On Assets | -0.086969994 |
| Return On Equity | -0.20228 |
| Revenue Per Share | 0.453 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 58,734,604 |
| Shares Percent Shares Out | 0.066700004 |
| Shares Short | 4,296,438 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 3,518,214 |
| Short Name | Adlai Nortye Group Ltd. |
| Short Percent Of Float | 0.0738 |
| Short Ratio | 21.6 |
| Source Interval | 15 |
| State | NJ |
| Symbol | ANL |
| Target High Price | 46.0 |
| Target Low Price | 20.0 |
| Target Mean Price | 28.6 |
| Target Median Price | 23.0 |
| Total Cash | 232,816,992 |
| Total Cash Per Share | 3.615 |
| Total Debt | 26,701,000 |
| Total Revenue | 18,056,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.66 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 8.6189 |
| Two Hundred Day Average Change | 5.2010994 |
| Two Hundred Day Average Change Percent | 0.6034528 |
| Type Disp | Equity |
| Volume | 165,027 |
| Website | https://www.adlainortye.com |
| Zip | 8,902 |